Cargando…
Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327372/ https://www.ncbi.nlm.nih.gov/pubmed/35883049 http://dx.doi.org/10.1186/s12876-022-02298-7 |
| _version_ | 1784757493436514304 |
|---|---|
| author | Chiorean, Michael V. Allegretti, Jessica R. Sharma, Puza P. Chastek, Benjamin Salese, Leonardo Bell, Elizabeth J. Peterson-Brandt, Jesse Cappelleri, Joseph C. Guo, Xiang Khan, Nabeel |
| author_facet | Chiorean, Michael V. Allegretti, Jessica R. Sharma, Puza P. Chastek, Benjamin Salese, Leonardo Bell, Elizabeth J. Peterson-Brandt, Jesse Cappelleri, Joseph C. Guo, Xiang Khan, Nabeel |
| author_sort | Chiorean, Michael V. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9327372 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93273722022-07-28 Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis Chiorean, Michael V. Allegretti, Jessica R. Sharma, Puza P. Chastek, Benjamin Salese, Leonardo Bell, Elizabeth J. Peterson-Brandt, Jesse Cappelleri, Joseph C. Guo, Xiang Khan, Nabeel BMC Gastroenterol Correction BioMed Central 2022-07-26 /pmc/articles/PMC9327372/ /pubmed/35883049 http://dx.doi.org/10.1186/s12876-022-02298-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Chiorean, Michael V. Allegretti, Jessica R. Sharma, Puza P. Chastek, Benjamin Salese, Leonardo Bell, Elizabeth J. Peterson-Brandt, Jesse Cappelleri, Joseph C. Guo, Xiang Khan, Nabeel Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis |
| title | Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis |
| title_full | Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis |
| title_fullStr | Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis |
| title_full_unstemmed | Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis |
| title_short | Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis |
| title_sort | correction to: real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327372/ https://www.ncbi.nlm.nih.gov/pubmed/35883049 http://dx.doi.org/10.1186/s12876-022-02298-7 |
| work_keys_str_mv | AT chioreanmichaelv correctiontorealworldcharacteristicstreatmentexperiencesandcorticosteroidutilisationofpatientstreatedwithtofacitinibformoderatetosevereulcerativecolitis AT allegrettijessicar correctiontorealworldcharacteristicstreatmentexperiencesandcorticosteroidutilisationofpatientstreatedwithtofacitinibformoderatetosevereulcerativecolitis AT sharmapuzap correctiontorealworldcharacteristicstreatmentexperiencesandcorticosteroidutilisationofpatientstreatedwithtofacitinibformoderatetosevereulcerativecolitis AT chastekbenjamin correctiontorealworldcharacteristicstreatmentexperiencesandcorticosteroidutilisationofpatientstreatedwithtofacitinibformoderatetosevereulcerativecolitis AT saleseleonardo correctiontorealworldcharacteristicstreatmentexperiencesandcorticosteroidutilisationofpatientstreatedwithtofacitinibformoderatetosevereulcerativecolitis AT bellelizabethj correctiontorealworldcharacteristicstreatmentexperiencesandcorticosteroidutilisationofpatientstreatedwithtofacitinibformoderatetosevereulcerativecolitis AT petersonbrandtjesse correctiontorealworldcharacteristicstreatmentexperiencesandcorticosteroidutilisationofpatientstreatedwithtofacitinibformoderatetosevereulcerativecolitis AT cappellerijosephc correctiontorealworldcharacteristicstreatmentexperiencesandcorticosteroidutilisationofpatientstreatedwithtofacitinibformoderatetosevereulcerativecolitis AT guoxiang correctiontorealworldcharacteristicstreatmentexperiencesandcorticosteroidutilisationofpatientstreatedwithtofacitinibformoderatetosevereulcerativecolitis AT khannabeel correctiontorealworldcharacteristicstreatmentexperiencesandcorticosteroidutilisationofpatientstreatedwithtofacitinibformoderatetosevereulcerativecolitis |